(Q73748188)
Statements
A phase I/II study of sequential, dose-escalated, high dose ifosfamide plus doxorubicin with peripheral blood stem cell support for the treatment of patients with advanced soft tissue sarcomas (English)
Bokemeyer C
Franzke A
Hartmann JT
Schöber C
Arseniev L
Metzner B
Link H
Kanz L